Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD

Clinical trial NCT06233110 · RECRUITING

Trial details

NCT number: NCT06233110
Sponsor: Stefanie Sarantopoulos, MD, PhD.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Graft Versus Host Disease

Start date: 2025-10-29
Primary completion: 2029-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.